Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paolo Baroldi
Pharmacokinetics of the Dual Melatonin Receptor Agonist Tasimelteon in Subjects With Hepatic or Renal Impairment
Journal of Clinical Pharmacology
Pharmacology
Related publications
Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Evacetrapib
European Journal of Clinical Pharmacology
Medicine
Pharmacology
The Pharmacokinetics and Safety of Darapladib in Subjects With Severe Renal Impairment
British Journal of Clinical Pharmacology
Pharmacology
Optimization of Dalbavancin in Patients With Hepatic or Renal Impairment
Pharmacology & Pharmacy
Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment
Antiviral Therapy
Infectious Diseases
Pharmacology
Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects With Severe Renal Impairment
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects With Renal Impairment
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects With Renal Impairment, Including End-Stage Renal Disease
Clinical Drug Investigation
Medicine
Pharmacology
The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Journal of Clinical Pharmacology
Pharmacology
Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib
Journal of Clinical Pharmacology
Pharmacology
